Captrust Financial Advisors Quanterix Corp Transaction History

Captrust Financial Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$19.54 - $28.66 $1,954 - $2,866	100 Added 0.63%	15,932 $435,000
Q3 2023 Nov 14, 2023	BUY	$21.15 - $27.96 $334,846 - $442,662	15,832 New	15,832 $429,000
Q2 2022 Aug 16, 2022	BUY	$15.06 - $30.65 $707 - $1,440	47 New	47 $1,000
Q3 2021 Nov 16, 2021	SELL	$45.91 - $59.67 $872 - $1,133	-19 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$43.3 - $67.17 $5,282 - $8,194	-122 Reduced 86.52%	19 $1,000
Q1 2021 May 17, 2021	BUY	$44.11 - $90.64 $6,219 - $12,780	141 New	141 $8,000

155

33.2M

30.6K

25.1K

Ticker QTRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,987,600
Market Cap $436M
Description
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.